Juniper Pharma Reports Second Quarter 2017 Financial And Operating Results Post author:Sam Post published:August 3, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Amgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks November 14, 2017 Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target March 21, 2017 Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML September 28, 2017
Amgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks November 14, 2017
Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target March 21, 2017
Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML September 28, 2017